Cohen's SAC Capital Cuts Stake in Invitrogen (IVGN) to 5.3%
Tweet Send to a Friend
In an amended 13D filing after the close on Invitrogen Corp. (Nasdaq: IVGN), Steven Cohen's SAC Capital disclosed a 5.3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
